Vascular Biogenics Ltd (VBLT)

[gr8db8]

VBLT at ASCO with link

https://iplanner.asco.org/am2015/AM2015.aspx

Saturday, May 30 | 1:15 PM - 4:45 PM
Gynecologic Cancer
Session Type: Poster Session
Track(s): Gynecologic Cancer
Presentation(s):
Abstract #5542
A phase I/II trial of multiple dose VB-111 and weekly paclitaxel in recurrent platinum-resistant Müllerian cancer.
Richard T. Penson, MD, MRCP
Massachusetts General Hospital and Harvard Medical School

Monday, Jun 1 | 1:15 PM - 4:45 PM
Central Nervous System Tumors
Session Type: Poster Session
Track(s): Central Nervous System Tumors
Presentation(s):
Abstract #2015
Onartuzumab plus bevacizumab versus placebo plus bevacizumab in recurrent glioblastoma (GBM): HGF and MGMT biomarker data.
Timothy Francis Cloughesy, MD
UCLA

Tuesday, Jun 2 | 8:00 AM - 11:00 AM
Central Nervous System Tumors
Session Type: Oral Abstract Session
Track(s): Central Nervous System Tumors
Presentation(s):
9:36 AM - 9:48 AM
Bevacizumab for Glioblastoma: Selection, Dose, and Schedule
Timothy F. Cloughesy, MD
University of California, Los Angeles